These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 12081625)
1. Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis. Gordon DJ; Tappe R; Meredith SC J Pept Res; 2002 Jul; 60(1):37-55. PubMed ID: 12081625 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues. Gordon DJ; Sciarretta KL; Meredith SC Biochemistry; 2001 Jul; 40(28):8237-45. PubMed ID: 11444969 [TBL] [Abstract][Full Text] [Related]
3. Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions. Gordon DJ; Meredith SC Biochemistry; 2003 Jan; 42(2):475-85. PubMed ID: 12525175 [TBL] [Abstract][Full Text] [Related]
5. Spatial separation of beta-sheet domains of beta-amyloid: disruption of each beta-sheet by N-methyl amino acids. Sciarretta KL; Boire A; Gordon DJ; Meredith SC Biochemistry; 2006 Aug; 45(31):9485-95. PubMed ID: 16878983 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of amyloid peptide fragment Aβ25-35 fibrillogenesis and toxicity by N-terminal β-amino acid-containing esapeptides: is taurine moiety essential for in vivo effects? Giordano C; Sansone A; Masi A; Masci A; Mosca L; Chiaraluce R; Pasquo A; Consalvi V Chem Biol Drug Des; 2012 Jan; 79(1):30-7. PubMed ID: 21995332 [TBL] [Abstract][Full Text] [Related]
7. New insights into the mechanism of Alzheimer amyloid-beta fibrillogenesis inhibition by N-methylated peptides. Soto P; Griffin MA; Shea JE Biophys J; 2007 Nov; 93(9):3015-25. PubMed ID: 17631541 [TBL] [Abstract][Full Text] [Related]
8. Water-soluble beta-sheet models which self-assemble into fibrillar structures. Janek K; Behlke J; Zipper J; Fabian H; Georgalis Y; Beyermann M; Bienert M; Krause E Biochemistry; 1999 Jun; 38(26):8246-52. PubMed ID: 10387070 [TBL] [Abstract][Full Text] [Related]
9. A two-step strategy for structure-activity relationship studies of N-methylated aβ42 C-terminal fragments as aβ42 toxicity inhibitors. Li H; Zemel R; Lopes DH; Monien BH; Bitan G ChemMedChem; 2012 Mar; 7(3):515-22. PubMed ID: 22307963 [TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of a highly soluble Aβ LeVatte MA; Lipfert M; Ladner-Keay C; Wishart DS Protein Expr Purif; 2019 Dec; 164():105480. PubMed ID: 31425755 [TBL] [Abstract][Full Text] [Related]
11. Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction Bakou M; Hille K; Kracklauer M; Spanopoulou A; Frost CV; Malideli E; Yan LM; Caporale A; Zacharias M; Kapurniotu A J Biol Chem; 2017 Sep; 292(35):14587-14602. PubMed ID: 28684415 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity. Viet MH; Ngo ST; Lam NS; Li MS J Phys Chem B; 2011 Jun; 115(22):7433-46. PubMed ID: 21563780 [TBL] [Abstract][Full Text] [Related]
13. Designing transmembrane alpha-helices that insert spontaneously. Wimley WC; White SH Biochemistry; 2000 Apr; 39(15):4432-42. PubMed ID: 10757993 [TBL] [Abstract][Full Text] [Related]
14. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents. Otvos L; Szendrei GI; Lee VM; Mantsch HH Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535 [TBL] [Abstract][Full Text] [Related]
15. Oligomerization of amyloid Abeta16-22 peptides using hydrogen bonds and hydrophobicity forces. Favrin G; Irbäck A; Mohanty S Biophys J; 2004 Dec; 87(6):3657-64. PubMed ID: 15377534 [TBL] [Abstract][Full Text] [Related]
16. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra. Barrow CJ; Yasuda A; Kenny PT; Zagorski MG J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791 [TBL] [Abstract][Full Text] [Related]
17. (R)-α-trifluoromethylalanine containing short peptide in the inhibition of amyloid peptide fibrillation. Botz A; Gasparik V; Devillers E; Hoffmann AR; Caillon L; Chelain E; Lequin O; Brigaud T; Khemtemourian L Biopolymers; 2015 Sep; 104(5):601-10. PubMed ID: 25968595 [TBL] [Abstract][Full Text] [Related]
18. N-Methylated peptide inhibitors of beta-amyloid aggregation and toxicity. Optimization of the inhibitor structure. Kokkoni N; Stott K; Amijee H; Mason JM; Doig AJ Biochemistry; 2006 Aug; 45(32):9906-18. PubMed ID: 16893191 [TBL] [Abstract][Full Text] [Related]